1. Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis. (February 2019) Authors: Loglio, A.; Alexandrov, A.; Renteria, S.C. Uceda; Tham, C.Y.L.; Greco, L.; Borghi, M.; Perbellini, R.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Lecchi, L.; Prati, D.; Ceriotti, F.; Lunghi, G.; Bertoletti, A.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 1 Page Start: e62 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Improvement of clinical parameters in HDV patients with advanced compensated cirrhosis treated with Bulevirtide monotherapy for 48 weeks. (March 2023) Authors: Degasperi, E.; Anolli, M.P.; Renteria, S.C. Uceda; Sambarino, D.; Borghi, M.; Perbellini, R.; Facchetti, F.; Loglio, A.; Monico, Sara; Fraquelli, M.; Costantino, A.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Omicron SARS-CoV-2 variant outbreak in vaccinated liver transplant (LT) recipients in 2022: A large spread of infection, a mild disease. (March 2023) Authors: Donato, M.F.; Dibenedetto, C.; Farina, E.; Toppetta, A.; Renteria, S.C. Uceda; Rigamonti, C.; Antonelli, B.; Caccamo, L.; Lombardi, A.; Bandera, A.; Ceriotti, F.; Lampertico, P. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗